The South African Medical Research Council (SAMRC) and Thermo Fisher Scientific Inc. have signed a Memorandum of Agreement (MOA) to collaborate on the establishment of a Centre of Excellence and training programme in the field of molecular biology and life sciences in South Africa. The purpose of this collaboration is to address the challenges faced […]
Abcam today announced the appointment of Markus Lusser as President. A seasoned Danaher executive, Markus joins Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio. His extensive commercial and digital experience across the life sciences and medical device industries will help build on Abcam’s momentum to deliver innovative solutions […]
New Location Positions CIL for Product Development and Future Growth Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), has announced it will be relocating and expanding its corporate headquarters to newly purchased space in Tewksbury, MA, to advance the operations and growth of the company. […]
Executive brings more than 25 years of experience in life sciences SAN JOSE, Calif. – Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Duseau’s appointment as its new president, succeeding interim president, Greg Milosevich. “Mary brings more than 25 […]
Key appointment to lead global commercial launch of eProtein Discovery platform Cambridge, UK: Nuclera, the biotechnology company enabling rapid protein expression and purification screening through its benchtop protein platform, today announced the appointment of Joseph Bertelsen as Chief Commercial Officer (CCO). With over 20 years’ commercial leadership experience in the life science tools and drug development […]
Following discussions with the board, the company’s founders Erik Gatenholm and Hector Martinez are leaving BICO after eight years. “I want to thank Erik and Hector for their efforts. Without them, the company would not have existed, let alone contributed to the change in the industry,” says Rolf Classon, Chairman of the Board. “I wish […]
Antibody-drug conjugates are gaining traction as an alternative or complementary therapy for different types of cancers Contest opened March 11, 2024; five winners will spend three weeks in Uppsala, Sweden testing their innovations Biotech firms and academic researchers interested in accessing a live bioprocess run for their technical and digital innovation projects are encouraged to […]
Company to Provide Broader Access to its AI-Driven Cell-Free Protein Production Platform SAN LEANDRO, Calif. — Tierra Biosciences, the company behind the world’s first platform for predictive AI-guided cell-free technology enabling high-throughput on-demand custom protein synthesis, announced today that it closed an $11.4M Series A round. The investment was led by Material Impact with participation from new […]
Novor V2.0 software with novel ML algorithm trained on HLA peptides yields immunopeptidome from de novo peptide sequencing with further improved IDs TwinScape ™ digital-twin technology with iRT ™ standards supports highest timsTOF performance with intelligent feedback – well beyond ‘just up-time’ New glyco-PASEF® method for ultra-high sensitivity 4D glycopeptide analysis Spectronaut® 18 software now available for Bruker ProteoScape ™ users Biognosys launches high-throughput ENRICHMENT plasma proteomics service for large-scale […]
The addition of the LSA increases Icosagen’s end-to-end service capabilities for drug companies developing therapeutics worldwide Tartu, Estonia and Salt Lake City, Utah, USA — Icosagen Group, an established research-driven organization providing services for the discovery and production of mammalian cell-derived biopharmaceuticals, today announced that it has acquired the LSA® platform from Carterra®, a leading provider of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
